Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cytran's IM-862 awarded antiangiogenesis patent

June 8, 1999

Photogen achieves favorable preliminary results with ocular melanoma treatment

June 8, 1999

Angiogenesis inhibitor SU-5416 poised to enter phase III testing in U.S. and Europe

June 7, 1999

Immune Response's membrane-bound cytokine-containing antitumor vaccines covered by U.S. patent

June 7, 1999

Cell Pathways updates clinical status of SAANDs

June 7, 1999

Immunex and Genentech reach TRAIL/Apo2L oncology agreement

June 7, 1999

New carbazole from Kyowa Hakko effective against chemotherapy-induced thrombocytopenia

June 4, 1999

Introgen Therapeutics commences phase I trial of i.v. p53 gene therapy

June 4, 1999

Spotlight on protein farnesyltransferase inhibitors

June 4, 1999

Phase II ECOG trial of didemnin B in melanoma patients yields indeterminate results

June 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...